Inner Banner

International 2022

breadCrumb

Submitted by admin on Thu, 06/02/2022 - 14:43
Type
common
  1. Abraham G, Noronha V, Rajappa S, Agarwal A, Batra U, Somani N, Raja T, Patil S, Kaushal AM, Joshi A, Radhakrishnan V, Singh N, Babu K G, Tewani R, Baghmar S, Dodagoudar C, Ananthakrishnan R, H P S, Sharma V, Menon N, Patil V, Joshi A, Gupta S, Prabhash K, Bajpai J (2022). The clinical utility and safety of Short-course Immune check point inhibitors (ICI) in multiple tumors - A real world multicentric study from India. International Journal of Cancer. 150(6):1045-1052. PMID: 34751432.
  2. Achrekar MS. (2022).Enhanced recovery after surgery (ERAS) nursing program. Asia-Pacific Journal of Oncology Nursing. 9(7):100041.PMID: 35620398
  3. Agarwal A, Khandelwal A, Pal K, Khare NK, Jadhav V, Gurjar M, Punatar S, Gokarn A, Bonda A, Nayak L, Kannan S, Gota V, Khattry N, Mittra I (2022). A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001). PLoS One. 17(2):e0262212. PMID: 35120140
  4. Alaggio R, Amador C, Anagnostopoulos I,... Laskar S, Tembhare P. et al. (2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid neoplasms. Leukemia. 36(7):1720-1748. PMID: 35732829
  5. Ashar S, Lipsa A, Khan N, Sarin R (2022). High cumulative risk of colorectal cancers and desmoid tumours and fibromatosis in South Asian APC mutation carriers. Journal of Medical Genetics. 59(5):492-495. PMID: 33766935
  6. Asija S, Chatterjee A, Yadav S, Chekuri G, Karulkar A, Jaiswal AK, Goda JS, Purwar R (2022). Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds. International Reviews of Immunology. PMID: 35938932
  7. Bajpai J, Kashyap L, Vallathol DH, Das A, Singh M, Pathak R, Rath S, Sekar A, Mohanta S, Reddy A, Joshi S, Nandhana R, Ravind R, Wadasadawala T, Nair N, Ghosh J, Parmar V, Gulia S, Desai S, Shet T, Thakur M, Patil A, Sarin R, Gupta S, Badwe R (2022). Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort. The Breast. 63:77-84. PMID: 35334242
  8. Bal M, Shah A, Rekhi B, Mittal N, Rane SU, Rabade K, Shetty O, Pantavaidya G, Nair D, Prabhash K, Aishwarya M, Govindarajan KK, Laskar S, Laskar SG, Patil A. (2022) Adamantinoma-Like Ewing Sarcoma of the head and neck: A case-series of a rare and challenging diagnosis. Head and Neck Pathology. 16(3):679-694.PMID: 35025056
  9. Bal M, Sharma A, Rane SU, Mittal N, Chaukar D, Prabhash K, Patil A (2022). Neuroendocrine Neoplasms of the Larynx: A Clinicopathologic Analysis of 27 Neuroendocrine Tumors and Neuroendocrine Carcinomas. Head and Neck Pathology. 16(2):375-387. PMID: 34401980.
  10. Banerjee A, Halder A, Jadhav P, Bankar R, Pattakine J, Hole A, Shah A, Goel A, CM Krishma, Srivastava S(2022). Metabolomics profiling of pituitary adenomas by Raman Spectroscopy, attenuated total reflection-fourier transform infrared spectroscopy, and mass spectrometry of serum samples. Analytical Chemistry. 94(34):11898-11907.
  11. Barua SA, Goswami N, Mishra N, Sawant UU, Varma A (2022). In silico and structure-based assessment of similar variants discovered in tandem repeats of BRCT domains of BRCA1 and BARD1 to characterize the folding pattern. ACS OMEGA.
  12. Behel V, Noronha V, Choughule A, Shetty O, Chandrani P, Kapoor A, Bondili SK, Bajpai J, Kumar R, Pai T, Bal M, Gurav M, Bapat P, Mittal N, Menon S, Patil V, Menon N, Dutt A, Prabhash K (2022). Impact of Molecular Tumor Board on the Clinical Management of Patients with Cancer. JCO Global Oncology. PMID: 35802838.
  13. Belavagi D, Bhandari R, Shafiq N, Gota V, Patil A, Pandey A, Mothsara C, Gupta R, Sahni N, Sharma N, Ray P, Kumar V, Sharma S, Malhotra S( 2022). A study to explore the appropriateness of dosing regimen of vancomycin in critically ill patients in a tertiary care unit of India. Germs. 2(2):238-252.PMID: 36504610
  14. Bhardwaj P, Gota V, Vishwakarma K, Pai V, Chaudhari P, Mohanty B, Thorat R, Yadav S, Gurjar M, Goda JS, Banerjee R. (2022) Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy. Journal of Controlled Release. 343:288-302. PMID: 35101477.
  15. Bhatia N, Vatsa R, Dhingra VK, Dhawan DK, Chadha VD. Evaluation of tetrofosmin cold kit fractionation using alternative new method of quality control for testing radiochemical purity. World Journal of Nuclear Medicine. 21(4):314-319. PMID: 36398310
  16. Bhattacharjee A, Banerjee S, Vishwakarma G, Pashchenko A (2022). highMLR: An open-source package for R with machine learning for feature selection in high dimensional cancer clinical genome time to event data. Expert System with Applications. 210:118432.
  17. Capistrano I R, Paul S, Boere I, Pantziarka P, Chopra S, Nout RA, Bouche G. Drug repurposing as a potential source of innovative therapies in cervical cancer.International Journal of Gynecological Cancer. 32(11):1377-1386. PMID: 36137575.
  18. Castaño-Vinyals G, Sadetzki S, Vermeulen R, Momoli F, Kundi M, Merletti F, Maslanyj M, Calderon C, Wiart J, Lee AK, Taki M, Sim M, Armstrong B, Benke G, Schattner R, Hutter HP, Krewski D, Mohipp C, Ritvo P, Spinelli J, Lacour B, Remen T, Radon K, Weinmann T, Petridou ET, Moschovi M, Pourtsidis A, Oikonomou K, Kanavidis P, Bouka E, Dikshit R, Nagrani R, Chetrit A, Bruchim R, Maule M, Migliore E, Filippini G, Miligi L, Mattioli S, Kojimahara N, Yamaguchi N, Ha M, Choi K, Kromhout H, Goedhart G, 't Mannetje A, Eng A, Langer CE, Alguacil J, Aragonés N, Morales-Suárez-Varela M, Badia F, Albert A, Carretero G, Cardis E.(2022) Wireless phone use in childhood and adolescence and neuroepithelial brain tumours: Results from the international MOBI-Kids study. Environment International. 160:10769. PMID: 34974237.
  19. Chakraborty A, Bose R, Bose K. (2022) Unraveling the dichotomy of enigmatic serine protease HtrA2. Frontiers in Molecular Biosciences. 9: 824846. PMID: 35187085
  20. Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F,Chopra S, Nout R, Tanderup K, Viswanathan A, Zacharipoulou C, Soria JC, Deutsch E, Gouy S, Morice P (2022). 1. Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F, Chopra S, Nout R, Tanderup K, Viswanathan A, Zacharipoulou C, Soria JC, Deutsch E, Gouy S, Morice P (2022). Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. 164(1):231-241. PMID: 34716024
  21. Chatterjee A, Asija S, Yadav S, Purwar R, Goda JS (2022). Clinical utility of CAR T cell therapy in brain tumors: Lessons learned from the past, current evidence and the future stakes. International Reviews of Immunology. 41(6):606-624.PMID: 36191126
  22. Chatterjee A, Bhadane M, Manjali JJ, Dasgupta A, Epari S, Sahay A, Patil V, Moiyadi A, Shetty P, Gupta T. Optimizing post-operative adjuvant therapy in elderly patients with newly-diagnosed glioblastoma: Single-institution audit of clinical outcomes from a tertiary-care comprehensive cancer centre in India. World Neurosurgery. 161:e587-e595. PMID: 35192971.
  23. Chatterjee G, Sriram H, Ghogale S, Deshpande N, Khanka T, Girase K, Verma S, Arolkar G, Dasgupta N, Narula G, Shetty D, Dhamne C, Moulik NR, Rajpal S, Patkar NV, Banavali S, Gujral S, Subramanian PG, Tmbhare PR (2022). Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease. British Journal of Haematology. 196(2): 374-379. PMID: 34476808.
  24. Chaubal K, Shetty D (2022). B-cell acute lymphoblastic leukemia with t(3;9)(q25;p13) involving the PAX-5 and MBNL1. Atlas of Genetics Cytogenetics in Oncology and Haematology.
  25. Chaudhary N, Joshi N, Doloi R, Shivashankar A, Thorat R, Dalal S (2022). Plakophilin3 loss leads to an increase in autophagy and radio-resistance. Biochemical and Biophysical Research Communications. 620:1-7. PMID: 35772211
  26. Cho HL, Murthy V, Mouw KW, D'Amico AV, Nguyen PL, Leeman JE, Dee EC (2022). Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy. Prostate. 82(11):1098-1106. PMID: 35652585.
  27. Chopade P, Chopra S, Jain J, Panda S, Patil A, Patil G, Mahantshetty U, Engineer R, Gurram L, Mittal P, Ghosh J, Gupta S, Shrivastava K (2022). Serial bone density changes in women undergoing pelvic (chemo) radiation: Results from PARCER trial. International Journal of Radiation Oncology, Biology, Physics. 114(3):463-471. PMID: 35870710
  28. Chopade P, Maitre P, David S, Panigrahi G, Singh P, Phurailtpam R, Murthy V (2022).Common iliac node positive prostate cancer treated with curative radiotherapy: N1 or M1a? International Journal of Radiation Oncology, Biology Physics. 114(4):711-717. PMID: 35870708
  29. Chopra S, Goda J, Mittal P, Mulani J, Pant S, Pai V, Kannan S, Deodhar K, Krishnamurthy M, Menon S, Charnalia M, Shah S, Rangarajan V, Gota V, Naidu L, Sawant S, Thakkar P, Popat P, Ghosh J, Rath S, Gulia S, Engineer R, Mahantshetty U, Gupta S (2022). Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial. BMJ Open. 12(4):e055765.
  30. Chopra S, Kalra B, Mulani J, Jain J, Gurram L, Mittal P, Alone M, Ghosh J, Rath S, Gulia S, Gupta S (2022). Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 114(4):812-819. PMID: 35850364.
  31. Chopra S, Ranjan N, Charnalia M, Kannan S, Engineer R, Dora T, Gurram P, Maheshwari A, Shylasree TS, Shrivastava S, Gupta S (2022). Late toxicity within a Phase III clinical trial of IG-IMRT in cervix cancer (PARCER): Reanalysis with time weighted adverse event reporting (MOSES). Radiotherapy and Oncology. 177:16-20. PMID: 36270474
  32. Chopra S, Ranjan N, Mittal P (2022). Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future. International Journal of Gynecoogical Cancer. 32(3):225-230. PMID: 35256407.
  33. Das S, Dholam K, Gurav S, Bendale K, Ingle A, Mohanty B, Chaudhari P, Bellare JR (2022). X-ray computed microtomography datasets for osteogenic nanofibrous coated titanium implants. Scientific Data. 9(1): 348. PMID: 35717538
  34. Dasgupta A, Gupta T, Maitre M, Kalra B, Chatterjee A, Krishnatry R, Goda JS, Shirsat N, Epari S, Sahay A, Janu A, Pungavkar S, Chinnaswamy G, Patil V, Moiyadi A, Shetty P, Jalali R. (2022) Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma. Strahlentherapie und Onkologie. 198(3):291-303. PMID: 35059761
  35. Deo A, Thorat R, Dhadve A, De A, Rekhi B, Ray P. (2022) IGF1R-α6 integrin-S100A4 network governs the organ-specific metastasis of chemoresistant epithelial ovarian cancer cells. Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease.1868 (1): 166282. PMID: 34600083
  36. Desai S, Dharavath B, Manavalan S, Rane A, Redhu A, Sunder R, Butle A, Mishra R, Joshi A, Togar T, Apte S, Bala P, Chandrani P, Chopra S, Bashyam M, Banerjee A, Prabhash K, Nair S, Dutt A(2022). Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer. 4(1): zcac006. PMID: 35252868
  37. Desai S, Mishra R, Ahmad S, Hait S, Joshi A, Dutt A (2022). TMC-SNPdb 2.0: an ethnic-specific database of Indian germline variants. Database: The Journal of Biological Databases and Curation.PMID: 35551364
  38. Dev ID, Puranik AD, Rangarajan V, Gupta T, Purandare NC, Agrawal A, Shah S. (2022) Radiation-Induced Meningioma in a Case of Medulloblastoma Treated 11 Years Ago-Detected on 68Ga-DOTANOC PET/CT. Clinical Nuclear Medicine. 47(1):e108-e110. PMID: 34183498.
  39. Dey P, Joshi M, Mujawar A, Malhotra R, De A (2022). Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer. Cellular Oncology (Dordr). 45(5):873-891. PMID: 35834098.
  40. Dhadve A, Ray P (2022). An active RUNX1-ID1/ID3 axis governs differentiation and chemoresistance of cancer stem cell population in epithelial ovarian cancer cells. Biocell. 46(1): 75-86.
  41. Dhawan A, Lokras A, Joshi G, Marwah M, Venkatraman M, Mohanty B, Darshan K, Chaudhaty P, Warawdekar U, Saraf M, Nagarsenkar M. Polysaccharide and monosaccharide guided liver delivery of Sorafenib Tosylate –a nano-strategic approach and comparative assessment of hepatospecificity. International Journal of Pharmaceutics. 625:122039. PMID: 35902059
  42. Dholam K, Singh G, Sathaye N, Gurav S, Shinde A (2022). Two-piece oral facial prothesis retained with magnets for a complex maxillary facial defect: A clinical report. The Journal of Prosthetic Dentistry. 128(6): 1365-1368.PMID: 34112522
  43. Dhumal S, Patil A, More A, Kamtalwar S, Joshi A, Gokarn A, Mirgh S, Thatikonda P, Bhat P, Murthy V, Chavan P, Oak A, Gore S, Bhattacharjee A, Patkar N, Kannan S, Shetty N, Rawat A, Achrekar M, Trivedi B, Laskar S, Chaturvedi P, Badwe R, Khattry N, Gupta S (2022). SARS-COV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study. International Journal of Infectious Diseases. 118: 95-103. PMID: 35192951
  44. Dongre HN, Mahadik S, Ahire C, Rane P, Sharma S, Lukmani F, Patil A, Chaukar D, Gupta S, Sawant SS (2022). Diagnostic and prognostic role of protein and ultrastructural alterations at cell-extracellular matrix junctions in neoplastic progression of human oral malignancy. Ultrastruct Pathol. PMID: 36049041.
  45. dos-Santos-Silva I, Gupta S, Orem J (2022). Shulman L. Global disparities in access to cancer care. Communications Medicine. 2:31.PMID: 35603309
  46. Dubey S, Mishra N, Goswami N, Siddiqui MQ, Varma A. Multimodal approach to characterize the tetrameric form of human PML-RBCC domain and ATO-mediated conformational changes. International Journal of Biogical Macromolecules. 223: 468-478. PMID: 36356867
  47. Duckworth E, Hole A, Deshmukh A, Chaturvedi P, CM Krishna Mora B, Roy D. Improving vibrational spectroscopy prospects in frontline clinical diagnosis: Fourier transform infrared on buccal mucosa cancer. Analytical Chemistry. 94(40):13642-13646. PMID: 36161799
  48. Dutta S, Khan N, Bose K, Poddar N (2022). A comparative in silico study to detect the effect of food-additives on metabolic protein and its perturbations compensated by osmolytes. International Journal of Biological Macromolecules.216:179-192. PMID: 35780921
  49. Gadre S, M M, Duari P, Chhatar S, Sharma A, Khatri S, Kode J, Barkume M, Kasinathan NK, Nagare M, Patkar M, Ingle A, Kumar M, Kolthur-Seetharam U, Patra M (2022). A rationally designed bimetallic platinum (II)-ferrocene antitumor agent induces non-apoptotic cell death and exerts in vivo efficacy. Chemistry. 28(46):e202201259. PMID: 35638709.
  50. Gandhi KA, Joshi A, Mehta P, Gurjar M, Rane P, Sharma J, Patil A, Nookala M, Noronha V, Prabhash K, Gota V. Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer. Cancer Chemotherapy Pharmacology. 89(6):751-759. PMID: 35441269.
  51. Ganguly R, Verma G, Ingle A, Kumar S, Sarma HD, Dutta D, Dutta B, Kunwar A, Ajish K, Bhainsa KC, Hassan PA, Aswal VK (2022). Structural, rheological and therapeutic properties of pluronic F127 hydrogel and beeswax based lavender oil ointment formulations. Journal of Molecular Liquids. 365: 120157.
  52. Gillessen S, Armstrong A, Attard G... Murthy V. et al. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology. 82(1):115-141. PMID: 35450732.
  53. Gohil D, Panigrahi GC, Gupta SK, Gandhi KA, Gera P, Chavan P, Sharma D, Sandur S, Gota V (2022). Acute and sub-acute oral toxicity assessment of 5-hydroxy-1, 4-naphthoquinone in mice. Drug and Chemical Toxicology. PMID: 35899689.
  54. Guha A, Goda JS, Dasgupta A, Mahajan A, Halder S, Gawde J, Talole S (2022). Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis. Frontiers in Oncology. PMID: 36263203
  55. Guha A, Vijan A, Agarwal U, Goda JS, Mahajan A, Shetty N, Khattry N. Imaging for plasma cell dyscrasias: What, when, and how? Frontiers in Oncology. 12: 825394. PMID: 35402253
  56. Gulia S, Kannan S, Ghosh J, Rath S, Maheshwari A, Gupta S (2022). Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis. ESMO Open. 7(5): 100558.PMID: 36007449
  57. Gulia S, Kannan S, Gupta S (2022). Maintenance therapy with a poly (ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: Updated individual patient data and trial-level meta-analysis. ESMO Open. 7(6):100632. PMID: 36356417
  58. Gupta A, Ojha S, Nagaraju P, Poojary M, Ravatale A (2022). Plateletpheresis Donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India. Transfusion Clinuque Et Biologique. 29(1): 65-69. PMID: 34302952
  59. Gupta N, Khan MA, Capasso G, Zacchia M (2022). Computational and structural analysis to assess the pathogenicity of Bardet-Biedl syndrome related missense variants identified in Bardet-Biedl syndrome 10 gene (BBS10). ACS Omega. 7(42):37654-37662. PMID: 36312387
  60. Gupta SK, Jadhav S, Gohil D, Panigrahi G, Kaushal RK, Gandhi K, Patil A, Chavan P, Gota V (2022). Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A in mice. Toxicology Reports. 9:1204-1212
  61. Gupta T, Kalra B, Goswami S, Deodhar J, Rane P, Epari S, Moidadi A, Dasgupta A, Chatterjee A, Chinnaswamy G (2022). Neuro-cognitive function and survival in children with average-risk medulloblastoma treated with hyperfractionated radiation therapy alone: long-term mature outcomes of a prospective study. Neuro-Oncology Practice .9(3):236-245.PMID: 35601967
  62. Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP (2022). Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior? Oral Oncology. 134: 106130. PMID: 36162191
  63. Gupta T, Maheshwari G, Kannan S, Nair S, Agarwal JP (2022). Should Sentinel Lymph Node Biopsy Be Considered the New Standard of Care for Early-Stage Clinically Node-Negative Oral Squamous Cell Carcinoma? Journal of Clinical Oncology. 40(15):1706-1709. PMID: 35298298.
  64. Gupta T, Maheshwari G, Kannan S, Nair S, Chaturvedi P, Agarwal J(2022). Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for practice and implications for research. Oral Oncology. 124: 105642. PMID: 34861565
  65. Gupta T, Nair S, Chaturvedi P, Agarwal J (2022). Can sentinel lymph-node biopsy become the new standard of care in clinically node-negative neck in early stage oral cancer? European Archives of Oto-Rhino-Laryngology. 279(10):5047-5048.PMID: 33439341
  66. Gupta T, Nayak P, Baviskar Y, Gupta M, Moiyadi A, Epari S, Janu A, Purandare N, Rangarajan V, Bagal B, Chatterjee A, Sastri GJ. Systemic inflammatory biomarkers in primary central nervous system lymphoma versus high-grade glioma: exploratory, comparative and correlative analysis. CNS Oncology. 11(2):CNS83.PMID: 35373582.
  67. Gupta T, Pervez S, Dasgupta A, Chatterjee A, Epari S, Chinnaswamy G, Jalali R (2022). Omission of upfront craniospinal irradiation in patients with low-risk WNT-pathway medulloblastoma is associated with unacceptably high risk of neuraxial failure. Clinical Cancer Research. 28(19):4180-4185. PMID: 35653134
  68. Gupta T, Thakkar P, Kalra B, Kannan S (2022). Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis. Reviews in Medical Virology. 32(2):e2276. PMID: 34245622.
  69. Gurav S, Dholam KP, Singh GP (2022). Treatment of Refractory Medicine Related Osteonecrosis of Jaw with Piezosurgical Debridement and Autologous Platelet Rich Fibrin: Feasibility Study. 33(3): e226-e230. Journal of Craniofacial Surgery. PMID: 34310422.
  70. Hande V, Chopra S, Kalra B, Abdel-Wahab M, Kannan S, Tanderup K, Grover S, Zubizarreta E, Rubio JAP (2022). Point-A vs Volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis. Radiotheray Oncology. 170:70-78. PMID: 35259419.
  71. Hole A, Jadhav P, Pansare K, Noothalapati H, Deshmukh A, Gota V, Chaturvedi P, CM Krishna (2022). Saliva Raman Spectroscopy: Understanding alterations in saliva of tobacco habitués and oral cancer subjects. Vibrational Spectroscopy. 122:103414
  72. Horeweg N, Mittal P, Gradowska PL, Boere I, Nout RA, Chopra S. A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer. Critical Reviews in Oncology/ Hematology. 172: 103638 PMID: 35189325.
  73. Ivanisenko N, Seyrek K, Hiller-Richter L, König C, Espe J, Bose K, Lavrik I.(2022) Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks. Trends in Cancer. 8(3):190-209.PMID: 34973957
  74. Jha A, Ravichandran G, De A, Srivastava R (2022).NANOTORRID®: Graphene-like properties of a gold/polypropylene nanocomposite and its photothermal application. Journal of Materials Research. 37:1183–1200
  75. Jobanputra K, Nayak L, Jain H, Shet T, Epari S, Bonda VN, Thorat J, Bagal B, Laskar S, Rangarajan V, Agrawal A, Gujral S, Khanna N, Goda J, Sengar M (2022). Diffuse large B-Cell lymphoma in the elderly: Real-world outcomes from a developing country. Clinical Lymphoma Myeloma and Leukemia. 22 (10):e898-e906. PMID: 35810145
  76. Johnson S, Dhamne C, Sankaran H, Gandhi KA, Rane P, Moulik NR, Jadhav SM, Gurjar M, Narula G, Banavali S, Gota V (2022). A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL). Cancer Chemotherapy and Pharmacology. 90(6):445-453.PMID: 36251032
  77. Joshi A, Butle A, Hait S, Mishra R, Trivedi V, Thorat R, Choughule A, Noronha V, Prabhash K, Dutt A (2022). Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation. Translational Oncology. 22:101461.PMID: 35653897
  78. Joshi A, Kalra D, Simha V, Menon N, Noronha V, Bakshi G, Prakash G, Pal M, Murthy V, Menon S, Sable N, Agrawal A, Rane P, Prabhash K (2022) Second-line therapy in testicular germ cell tumours: results from a tertiary cancer care centre in India. Ecancermedicalscience 16:1408. PMID: 36072230
  79. Joshi R, Thomas M, Patkar S, Gupta AM, Panhale K, Rane PP, Ambulkar R, Goel M, Shrikhande SV, Agarwal V(2022). Impact of enhanced recovery pathway in 408 gallbladder cancer resections. HPB (Oxford). 24(1):47-56. PMID: 34187721.
  80. Joshi T, Mantri M, Hadgaonkar S, Rao N, Dhondge R, Jaiswal D, Mathews S, Qayyumi B, Chaturvedi P, Shankhdhar VK. Outcome Analysis of Advanced Oral Cancers Requiring Large Composite Fibular Osteocutaneous Flap Reconstruction: Experience from a Tertiary Care Cancer Hospital. Annals of Plastic Surgery. 88(6):635-640.PMID: 35502967.
  81. Khamkar V, Narasimhan M, Govekar R (2022). Improved identification of hydrophobic proteins by optimization of LC conditions within the LC-MS Run - A practical strategy for scanty clinical samples. Biomedical Journal of Scientific & Technical Research. 43(4): 34886-34892.
  82. Khan MA, Siddiqui MQ, Kuligina E, Varma AK (2022). Evaluation of conformational transitions of h-BRCA2 functional domain and unclassified variant Arg2502Cys using multimodal approach. International Journal of Biological Macromolecules. . 209: Part A: 716-724. PMID: 35413318
  83. Khan MA, Varma AK (2022). In silico and structure-based assessment to classify VUS identified in the α-helical domain of BRCA2.Journal of Biomolecular Structure and Dynamics. . PMID: 36404616.
  84. Khanna N, Ghosh Laskar S, Gupta T, Agarwal JP (2022). Compliance with Radiotherapy Treatment in an Apex Cancer Center of India. JCO Global Oncology. 8:e2100201. PMID: 34985910
  85. Khoury JD, Solary E, Abla O, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Khattry N, Subramanian PG. et al. (2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic/dendritic neoplasms. Leukemia. 36(7):1703-1719. PMID: 35732831.
  86. Khurud P, Gupta A, Krishnatry R, Panigrahi G, Phurailatpam RD, Menon S, Pal M, Bakshi G, Prakash G, Murthy V (2022). Optimizing target volume for adjuvant radiotherapy in penile cancer. Practical Radiation Oncology.
  87. Khurud P, Krishnatry R, Telkhade T, Patil A, Prakash G, Joshi A, Pal M, Noronha V, Menon S, Bakshi G, Prabhash K, Murthy V (2022). Impact of Adjuvant Treatment in pN3 Penile Cancer. Clinical Oncology (R Coll Radiol). 34 (2): 172-178. PMID: 34732295
  88. Krishnamurthy MN, Pradosh A, Varghese D, Halder S (2022). Clinical pharmacologist from the eyes of a clinical pharmacologist: A questionnaire‑based survey. European Journal of Clinical Pharmacology. 78(12):2003-2011. PMID: 36305906
  89. Krishnamurthy R, Mummudi N, Goda JS, Chopra S, Heijmen B, Swamidas J (2022). Using artificial intelligence for optimization of the processes and resource utilization in radiotherapy. JCO Global Oncology. PMID: 36395438.
  90. Krishnatry R, Gudi S, Siwach A, Patil A, Rajesh KR, Shekhar H, Sutar V, Chatterjee A, Goda J, Jalali R, Gupta T (2022). Impact of immobilisation and image guidance protocol on planning target volume margins for supine craniospinal irradiation. Reports of Practical Oncology and Radiotherapy. 27(2):250-259. PMID: 36299390
  91. Kumar M, Noronha S, Rangaraj N, Moiyadi A, Shetty P, Singh VK (2022). Choice of intraoperative ultrasound adjuncts for brain tumor surgery. BMC Medical Informatics and Decision Making. 22(1):307. PMID: 36437463.
  92. Kumar P, Ambulkar R, Ranganathan P, Patil S (2022). Use of the McGRATH™ MAC videolaryngoscope to evaluate the ability of anesthetists to give effective cricoid pressure an interventional study. Journal of Anaesthesiology Clinical Pharmacology. 48(3): 471-422.
  93. Kumar R, Abreu C, Toi M, Saini S, Casimiro S, Arora A, Paul AM, Velaga R, Rameshwar P, Lipton A, Gupta S, Costa L. Oncobiology and treatment of breast cancer in young women. Cancer Metastasis Reviews. 41(3):749-770. PMID: 35488982.
  94. Lall S, Bhat V, Biswas S, Joshi A, Janu A (2022). Delftia acidovorans: An unusual pathogen from an adenocarcinoma lung patient with pleural effusion. Journal of Global Infectious Diseases.
  95. Laskar S, Sinha S, Chatterjee A, Khanna N, Manjali JM, Puri A, Gulia A, Nayak P, Vora T, Chinnaswamy G, Prasad M, Bajpai J, Juvekar S, Desai S, Janu A, Rangarajan V, Purandare N, Shah S, Rekhi B, Jambhekar N, Muckaden M, Kurkure P (2022). Radiotherapy dose escalation in unresectable Ewing's sarcoma: Final results of a phase III randomized controlled trial. International Journal of Radiation Oncology, Biology, Physics. PMID: 35568246
  96. Laskar SG, Sinha S, Pai DP, Nair D, Budrukkar A, Swain M, Kimar A, Moiyadi A, Shetty P, Roy V, Johnny C, Murthy V, Gupta T, Menon N, Patil V, Noronha V, Joshi A, Prabhash K, Agarwal JP (2022). Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomes. Radiotherapy Oncology. 170: 151–158. PMID: 35219800."
  97. Laskar SG, Sinha S, Singh M, Mummudi N, Mittal R, Gavarraju A, Budrukkar A, Swain M, Agarwal JP, Gupta T, Murthy V, Mokal S, Patil V, Noronha V, Joshi A, Menon N, Prabhash K (2022). Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy: a Phase II Prospective Study of Outcomes, Toxicity and Quality of Life. Clinical Oncology(R Coll Radiol).34(4):220-229. PMID: 34872822
  98. Mahantshetty U, Naga P, Nachankar A, Ghadi Y, Dheera A, Scaria L, Epili D, Chopra S, Lavanya G, Shrivastava S (2022). Set-Up Errors, Organ Motion, Tumour Regression and its Implications on Internal Target Volume-Planning Target Volume during Cervical Cancer Radiotherapy: Results from a Prospective Study. Clinical Oncology (R Coll Radiol). 34(3): 189-197. PMID: 34736842
  99. Maheshwari A, Gupta S, Deodhar K, Chopra S, Rangarajan V, Purandare N, Mahantshetty U(2022). Preoperative imaging with positron emission tomography and computed tomography (18F-FDG PET/CT) or contrast-enhanced computed tomography (CECT) scan in operable cervical cancer: a prospective study. European Journal of Gynaecological Oncology. .43: 32-39
  100. Maitre M, Gupta T, Maitre P, Chatterjee A, Dasgupta A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Krishnatry R, Goda J, Jalali R (2022). High-dose salvage re-irradiation in recurrent/progressive adult diffuse gliomas: development of a novel prognostic scoring system. Cancer Radiotherapy. 26(8):994-1001.PMID: 35715356
  101. Maitre P, Sood S, Pathare P, Krishnatry R, Agarwal A, Rangarajan V, Murthy V (2022). Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: Implications for potential salvage. Radiotherapy Oncology. 169: 71-76.PMID: 35189154.
  102. Mal A, Prabhuraj RS, Malhotra R, Valvi S, Ingle A, Srivastava R, De A, Bandopadhyaya R (2022). pH-responsive sustained delivery of doxorubicin using aminated and PEGylated mesoporous silica nanoparticles leads to enhanced antitumor efficacy in pre-clinical orthotopic breast cancer model. Journal of Drug Delivery Science and Technology. 77: 103800.
  103. Mehta D, Roy S, Joshi P, Parab M, Waghmare S. (2022)Secretary phospholipase (sPLA2IIA) loss impairs tumorigenic and metastatic potential in breast cancer cells. Biochemical and Biophysical Research Communications. 597:102-108. PMID: 35134607
  104. Mehta P, Sinha S, Kashid S, Chakraborty D, Mhatre R, Murthy V (2022). Exploring texture analysis to optimize bladder preservation in muscle invasive bladder cancer. Clinical Genitourinary Cancer. PMID: 3662869
  105. Menon NS, Noronha V, Patil VM, Joshi A, Bhattacharjee A, Kalra D, Laskar SG, Mathrudev V, Nawale K, Bhelekar AS, Prabhash K (2022). Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin. Cancer Medicine. (21):3939-3948. PMID: 35343648.
  106. MG Sudharsan M, Chikhale R, Nanaware N, Dalvi S, Venkatraman P. (2022) A druggable pocket on PSMD10Gankyrin that can accommodate an interface peptide and doxorubicin. European Journal of Pharmacology. 915: 174718. PMID: 34953804
  107. Mhatre S, Lacey B, Sherliker P, Chatterjee N, Rajaraman P, Goel M, Patkar S, Ostwal V, Patil P, Shrikhande SV, Chitkara G, Badwe R, Lewington S, Dikshit R (2022). Reproductive factors and gall-bladder cancer, and the effect of common genetic variants on these associations: a case-control study in India. International Journal of Epidemiology. 51(3):789-798. PMID: 34550362.
  108. Miriyala R, Mahantshetty U, Maheshwari A, Gupta S (2022). Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future. International Journal of Gynecological Cancer 32(3):260-265. PMID: 35256411.
  109. Mishra A, Janu A, Trivedi K, Shetty P, Singh V, Moiyadi A (2022). Subpial en bloc resection improves extent of resection in infiltrating gliomas – a propensity matched comparative cohort analysis. Clinical Neurology and Neurosurgery. 215:101977PMID: 35305392
  110. Mishra SK, Dhadve AC, Mal A, Reddy BPK, Hole A, CM Krishna, Ray P, Srivastava R, De A (2022). Photothermal therapy (PTT) is an effective treatment measure against solid tumors which fails to respond conventional chemo/radiation therapies in clinic. Biomaterials Advances. 143:213153. PMID: 36343390
  111. Mittal P, Chopra S, Charnalia M, Dora T, Engineer R, Mulani J, Scaria L, Prajapati K, Kannan S, Gurram L, Mahantshetty U, Gupta S, Shrivastava SK (2022). Patterns of Relapse after Adjuvant Chemoradiation for Cervical Cancer in a Phase 3 Clinical Trial (PARCER): An Evaluation of Updated NRG Oncology/RTOG Target Delineation Guidelines. International Journal of Radiation Oncology Biology Physics. 113(2):369-378. PMID: 35157993.
  112. Mohanty P, Shetty D, Liehr T, Mrasek K, Khattry N (2022). Intrachromosomal amplification of BCR expressed as homogenously staining region (hsr) in a case of acute myeloid leukemia with myelodysplasia-related changes. International Journal of Laboratory Hematology. 44(6):993-994. PMID: 35534180
  113. Moitra P, Chatterjee A, Kota PK, Epari S, Patil V, Dasgupta A, Kowtal P, Sarin R, Gupta T.(2022) Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study. Journal of Neuro-oncology. 156(3):625-634. PMID: 35037156
  114. Morge S, Makani V, Pradhan S, Devre P, More S, Vaidya M, D'Mello C. Biomarker potential of vimentin in oral cancers.Life. 12(2): 150.PMID: 35207438
  115. More MH (2022), Varankar SS, Naik RR, Dhake RD, Ray P, Bankar RM, Mali AM, Subbalakshmi AR, Chakraborty P, Jolly MK, Bapat SA. A Multistep tumor growth model of high grade serous ovarian carcinomaidentifies hypoxia associated signatures. Cells Tissues Organs. PMID: 35970135.
  116. Mukherjee A, Pednekar CB, Kolke SS, Kattimani M, Duraisamy S, Burli AR, Gupta S, Srivastava S (2022). Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer. Proteomes. 10(2):13. PMID: 35645371
  117. Mukherjee S, Maddalena M, Lü Y, Martinez S, Nataraj NB, Noronha A, Sinha S, Teng K, Cohen-Kaplan V, Ziv T, Arandkar S, Hassin O, Chatterjee R, Pirona AC, Shreberk-Shaked M, Gershoni A, Aylon Y, Elazar Z, Yarden Y, Schramek D, Oren M. Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins. Proceedings of the National Academy of Sciences. 119(17):e2119644119. PMID: 35439056.
  118. Mukherjee S, Sakpal A, Mehrotra M, Phadte P, Rekhi B, Ray P (2022). Homo and heterotypic cellular cross-talk in epithelial ovarian cancer impart pro-tumorigenic properties through differential activation of the Notch3 pathway. Cancers. 14(14): 3365. PMID: 35884426
  119. Mukherjee S, Sharma S, Soni V, Joshi A, Gaikwad A, Bellare J, Kode J. Improved osteoblast function on titanium implant surfaces coated with nanocomposite Apatite-Wollastonite-Chitosan- an experimental in-vitro study. Journal of Materials Science: Materials in Medicine. 33(3):25. PMID: 35190908.
  120. Mukund Sudharsan MG, Dalvi S, Venkatraman P (2022). Snapshots of urea-induced early structural changes and unfolding of an ankyrin repeat protein at atomic resolution. Protein Science. 31(12):e4515. PMID: 36382986.
  121. Mulla SW, Venkatraman P (2022). Novel Nexus with NFκB, β-catenin, and RB1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role. International Journal of Biochemistry & Cell Biology. 146: 106209. PMID: 35378311.
  122. Mulye G, Gurram L, Chopra S, Gupta S, Ghosh J, Gulia S, Maheshwari A, Kerkar R, Shylasree TS, Scaria L, Dheera A, Ghadi Y, Kohle S, Kadam S, Mahantshetty U (2022). Clinical outcomes of patients treated with template based high-dose-rate interstitial brachytherapy boost for post-operative recurrent gynecological malignancies: A retrospective analysis. Journal of Contemporary Brachytherapy. 14(6): 560-567.
  123. Mummudi N , Tibdewal A, Gupta T, Patil V, Prabhash K, Agarwal JP (2022). Tackling brain metastases from lung cancer during the COVID-19 pandemic. Cancer Reports. 5:e1276. PMID: 32881412
  124. Murthy V, Adsul K, Maitre P, Singhla A, Singh P, Panigrahi G, Raveendran V, Phurailatpam R (2022). Acute and late toxicity of prostate-only or pelvic SBRT in prostate cancer: A Comparative study. International Journal of Radiation Oncology, Biology, Physics. 114(2):275-282. PMID: 35724773
  125. Narasimhan M, Khamkar V, Tilwani S, Dalal SN, Shetty D, Subramanian PG, Gupta S, Govekar R. Atypical activation of signaling downstream of inactivated Bcr-Abl mediates chemoresistance in chronic myeloid leukemia. Journal of Cell Communication and Signaling. 16(2):207-222. 2022. PMID: 34596797.
  126. Nimbalkar VK, Gangar J, Shai S, Rane P, Mohanta SK, Kannan S, Ingle A, Mittal N, Rane S, Mahimkar MB (2022). Prevention of carcinogen-induced oral cancers by polymeric black tea polyphenols via modulation of EGFR-Akt-mTOR pathway. Scientific Reports. 12(1):14516. PMID: 36008552
  127. Noronha V, Chougule A, Chandrani P, Kaushal RK, Patil VM, Menon N, Kapoor A, Chopade S, Singh A, Shetty O, Dutt A, Banavali S, Prabhash K. Lung cancer with dual EGFR and ALK driver alterations at baseline: A retrospective observational cohort study. Acta Oncologica. 61(9):1143-1147. PMID: 35972844.
  128. Noronha V, Patil VM, Menon NS, Joshi A, Goud S, More S, Kannan S, Pawar A, Nakti D, Yadav A, Shah S, Mahajan A, Janu A, Kumar R, Tibdewal A, Mummudi N, Agarwal JP, Banavali SD, Prabhash K (2022). Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: A randomized clinical trial. Esophagus. 19(4):670-682. PMID: 35614161
  129. Ojha S, Poojary M, Mokalikar U, Sumathi SH, Kumar A, Gupta A, Saha S (2022). The determinants of donor safety and product quality in optimization of apheresis granulocyte harvest: An experience from a tertiary care oncology centre in India. Transfusion and Apheresis Science. 61(5): 103445. PMID: 35450807
  130. Ostwal V, Ramaswamy A, Gota V, Bhargava PG, Srinivas S, Shriyan B, Jadhav S, Goel M, Patkar S, Mandavkar S, Naughane D, Daddi A, Nashikkar C, Shetty N, Ankathi SK, Banavali SD. Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH). Oncologist. 27(3):165-e222. PMID: 35274724
  131. Pal K, Raghuram GV, Dsouza J, Shinde S, Jadhav V, Shaikh A, Rane B, Tandel H, Kondhalkar D, Chaudhary S, Mittra I (2022). A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice. Scientific Reports. 12(1):17209. PMID: 36241685
  132. Panda G, Kalra B, Rishi A, Khanna N, Kakoti S, Sridhar E, Shet T, Sengar M, Nayak L, Bagal B, Jain H, Laskar S, Goda J.(2022) Long-term clinical outcomes and sequelae of therapy in early-stage orbital mucosa-associated lymphoid tissue lymphoma. Clinical Lymphoma Myeloma and Leukemia. 22(7):513-522. PMID: 35027338
  133. Pandya R, Uppangala S, Salian S, Gupta S, Kalthur G, Schlatt S, Adiga SK (2022). Short-term hypothermic holding of mouse immature testicular tissue does not alter the expression of DNA methyltransferases and global DNA methylation level, post-organotypic culture. Frontiers in Endocrinology.13:854297. PMID: 35399926
  134. Pansare K, Mohanty B, Dhotre R, Pettiwala AM, Parab S, Gupta N, Gera P, Gardi N, Dugge R, Sahu P, Alhans R, Kowtal P, Chaudhari P, Sarin R. (2022) Aspirin Inhibition of Group VI Phospholipase A2 Induces Synthetic Lethality in AAM Pathway Down-Regulated Gingivobuccal Squamous Carcinoma. Cells. 11(1):123. PMID: 35011685
  135. Pansare K, Vaid A, Singh S, Rane R, Visani A, Ranjan M, CM Krishna, Sarin R, Joseph A (2022). Effect of Cold Atmospheric Plasma Jet and Gamma Radiation Treatments on Gingivobuccal Squamous Cell Carcinoma and Breast Adenocarcinoma Cells. Plasma Chemistry and Plasma Processing. 42: 163–178.
  136. Pantvaidya G, Joshi S, Nayak P, Kannan S, Desouza A, Poddar P, Prakash G, Vijaykumaran P, Nair D, Vaish R, Patkar S, Niyogi D, Joshi P, Chaudhari V, Sigh V, Mathews S, Pramesh CS, Badwe R, Puri A (2022). Surgical Site Infections in patients undergoing major oncological surgery during the COVID-19 paNdemic (SCION): A propensity-matched analysis. Journal of Surgical Oncology. 125(3):327-335. PMID: 34729779
  137. Parekh D, Patil VM, Nawale K, Noronha V, Menon N, More S, Goud S, Jain S, Mathrudev V, Peelay Z, Dhumal S, Jogdhankar S, Prabhash K (2022) Audit of screen failure in 15 randomised studies from a low and middle-income country. Ecancermedicalscience. 16:1476
  138. Parsaniya BS, Pinto A, Tambe M, D'Silva SZ, Singh M (2022). Identification of the novel HLA allele, HLA-DRB1*14:245, in an individual from Northern India. HLA. PMID: 36006395
  139. Parsaniya BS, Tambe M, D'Silva SZ, Singh M (2022). Identification of the HLA-A allele, HLA-A*11:03:01:02, in two individuals in a Western Indian family. HLA. PMID: 36006407
  140. Parui A, Mishra V, Dutta S, Bhaumik P, Bose K (2022). Inter-subunit crosstalk via PDZ synergistically governs allosteric activation of proapoptotic HtrA2. Structure. 30(9): 1307-1320. e5.PMID: 35738282
  141. Patel U, Kannan S, Rane SU, Mittal N, Gera P, Patil A, Manna S, Shejwal V, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB. Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab. British Journal of Cancer. 126(10):1439-1449. PMID: 35140342
  142. Patil R, Gupta T, Maitre M, Dasgupta A, Sahay A, Epari S, Shirsat N, Chatterjee A, Krishnatry R, Goda JS, Moiyadi A, Patil V, Chinnaswamy G, Bano N, Jalali R (2022). Clinical audit of survival outcomes and prognostic factors in adolescents and adults with medulloblastoma. Journal of Adolescent and Young Adult Oncology. 11(1):68-77. PMID: 33891492
  143. Patil V, Menon N, Chatterjee A, Tonse R, Choudhari A, Mahajan A, Puranik A, Epari S, Jadhav M, Pathak S, Peelay Z, Walavalkar R, Muthuluri H, Krishna M, Chandrasekharan A, Pande N, Gupta T, Banvali S, Jalali R (2022). Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial. EClinicalMedicine. 49: 101449.PMID: 35747192
  144. Patil V, Noronha V, Joshi A, Menon N, Mathrudev V, Bhattacharjee A, Chandrasekharan A, Vallathol D, Dsouza H, Srinivas S, Mandal T, Chaturvedi P, Chaukar D, Pai P, Nair S, Thiagrajan S, Laskar S, Nawale K, Babanrao Dhumal S, Tambe R, Banavali S, Prabhash K. RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation. Oral Oncology.128: 105816. PMID: 35367787.
  145. Patwardhan S, Patil V, Baheti A, Shukla A, Qureshi S (2022). Relapse of acute lymphoblastic leukemia presenting with ovarian torsion: A rare case report. Pediatric Hematology Oncology Journal. 7(3): 81-83.
  146. Paul S, Arya S, Mokul S, Baheti A, Kumar S, Ramaswamy A, Ostwal V, Chopra S, Saklani A, deSouza A, Kazi M, Engineer R. Extramural vascular invasion as an independent prognostic marker in locally advanced rectal cancer: propensity score match pair analysis. Abdominal Radiology. 47(11):3671-3678. PMID: 36085377
  147. Pawar A, Chowdhury OR, Chauhan R, Talole S, Bhattacharjee A. (2022) Identification of key gene signatures for the overall survival of ovarian cancer. Journal of Ovarian Research. 15:12. PMID: 35057823
  148. Pilankar A, Singhavi H, Raghuram G, Siddiqui S, Khare N, Jadhav V, Tandel H, Pal K, Bhattacharjee A, Chaturvedi P, Mittra I (2022). A pro-oxidant combination of resveratrol and copper down regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004).Frontiers in Oncology. PMID: 36185249
  149. Pinto AS, Tambe M, D'Silva SZ, Singh M (2022). Identification of the novel HLA-B*51:01:01:108 allele and confirmation of HLA-B*40:387 in two Indian individuals. HLA.
  150. Poojari R, Mohanty B, Kadwad V, Suryawanshi D, Chaudhari P, Khade B, Srivastava R, Gupta S, Panda D.(2022) Combinatorial Cetuximab targeted polymeric nanocomplexes reduce PRC1 level and abrogate growth of metastatic hepatocellular carcinoma in vivo with efficient radionuclide uptake. Nanomedicine: Nanotechnology, Biology and Medicine. 41: 102529.PMID: 35104671
  151. Pramesh CS, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, de Andrade VP, Hunter DJ, Gopal S, Gospodarowicz M, Gunasekera S, Ilbawi A, Kapambwe S, Kingham P, Kutluk T, Lamichhane N, Mutebi M, Orem J, Parham G, Ranganathan P, Sengar M, Sullivan R, Swaminathan S, Tannock IF, Tomar V, Vanderpuye V, Varghese C, Weiderpass E. Priorities for cancer research in low- and middle-income countries: a global perspective. Nature Medicine. 28(4):649-657. PMID: 35440716.
  152. Puja R, Chakraborty A, Dutta S, Bose K (2022). Purification, characterization and functional site prediction of the vaccinia-related kinase 2A small transmembrane domain. MethodsX. 9:101704. PMID: 35518920
  153. Punatar S, Kandekar S, Khattry N, Gokarn A, Prabhash K, Bakshi A, Rane P, Mathew L, Chiplunkar S, Kode J( 2022). CD26 expression on donor harvest as a risk predictive biomarker for developing Graft-versus-Host Disease post-Allogeneic Hematopoietic Stem Cell Transplantation: A tenyear followup study. Cancer Biomarkers. 33(1): 17-28. PMID: 34334382.
  154. Punatar S, Katti K, Rajamanickam D, Patil P, Dhakan C, Bagal B, Gokarn A, Bonda A, Nayak L, Gurjar M, Kannan S, Chiplunkar S, Gota V, Khattry N (2022). Cell Transplantation. PMID: 35435039
  155. Raghavan R, Koyande N, Beher R, Chetlangia N, Ramadwar M, Pawade S, Thorat R, Hengel J, Sklyarova T, Roy F, Dalal SN.(2022) Plakophilin3 loss leads to increased adenoma formation and rectal prolapse in APC min mice. Biochemical and Biophysical Research Communications. 58: 14-19. 34823217
  156. Rajak J, Tambe M, D'Silva SZ, Singh M (2022). Identification of the novel HLA-A*68:175:02 and -A*68:287 alleles in Indian individuals. HLA. 100(5):517-518. PMID: 35896953
  157. Rajak J, Tambe M, Phuntsok T, D'Silva SZ, Singh M (2022. The novel HLA-B*07:461 allele and confirmation of the HLA-C*15:193 allele in individuals from Eastern India. HLA. 100(3):262-263.
  158. Ramaswamy A, Bhargava P, Srinivas S, Kannan S, Bhandare M, Chaudhari V, Mantri A, Kapoor A, Das S, Booma N, Chaugule D, Shrikhande SV, Ostwal V (2022). Perioperative modified FLOT versus EOX in locally advanced resectable gastric and gastro-oesophageal junction adenocarcinoma: Results of a matched-pair analysis. Journal of Gastrointestinal Cancer.PMID: 36242748
  159. Ranjan N, Chopra S, Mangaj A, Rane P, Charnalia M, Kannan S, Dora T, Engineer R, Mahantshetty U, Gurram L, Mittal P, Ghosh J, Maheshwari A, Shylasree TS, Gupta S, Shrivastava SK (2022). Months and severity score (MOSES) in a phase III trial (PARCER): A new comprehensive method for reporting adverse events in oncology clinical trials. EClinicalMedicine. 47: 101390. PMID: 35480072
  160. Razis E, Escudero MJ, Palmieri C, Mueller V, Bartsch R, Rossi G, Gampenrieder SP, Kolberg HC, Zdenkowski N, Pavic M, Connolly RM, Rosset L, Arcuri J, Tesch H, Vallejos C, Retamales J, Musolino A, Del Mastro L, Christodoulou C, Aebi S, Paluch-Shimon S, Gupta S, Ohno S, Macpherson I, Ekholm M, Zaman K, Vidal M, Chakiba C, Fumagalli D, Thulin A, Witzel I, Kotecki N, Gil-Gil M, Linderholm B (2022). Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force. ESMO Open. 7(3): 100483. PMID: 35576695
  161. Reddy D, Bhattacharya S, Shah S, Rashid M, Gupta S (2022). DNA methylation mediated downregulation of histone H3 variant H3.3 affects cell proliferation contributing to the development of HCC.Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.1868: 166284.PMID: 34626773
  162. Rekhi B, Dodd L, Dharavath B, Dutt A (2022). Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result. Diagnostic Cytopathology. 50(12): E367-372. PMID: 35929754
  163. Rubagumya F, Sengar M, Ka S, Hammad N, Booth C, Karim S (2022). Choosing wisely—barriers and solutions to implementation in low and middle-income countries. Current Oncology. 29(7): 5091-5096. PMID: 35877263
  164. Saikia D, Jadhav P, Hole A, CM Krishna, Singh SP. Unraveling the secrets of colistin resistance with label-free Raman Spectroscopy. Biosensors. 12(9): 749.
  165. Saikia D, Jadhav P, Hole AR, CM Krishna, Singh SP (2022). Growth kinetics monitoring of gram-negative pathogenic microbes using Raman Spectroscopy. Applied Spectroscopy. 76(10):1263-1271. PMID: 35694822
  166. Sangle A, Bhat V, Biswas S, Tikhile A (2022). Microbiology, risk factors and clinical outcomes of Ventilator associated pneumonia at tertiary care Cancer hospital. MedPulse International Journal of Microbiology. 21(1): 15-20.
  167. Saju AC, Chatterjee A, Sahu A, Gupta T, Krishnatry R, Mokal S, Sahay A, Epari S, Prasad M, Chinnaswamy G, Agarwal JP, Goda JS (2022). Machine-learning approach to predict molecular subgroups of medulloblastoma using multiparametric MRI-based tumor radiomics. British Journal of Radiology. 23:20211359. PMID: 35262407.
  168. Sali A, Shah A, Prakash G, Murthy V, Bakshi G, Joshi A, Aggarwal A, Desai S, Menon S (2022). Predictors of pelvic lymph nodal metastasis in penile squamous cell carcinoma- Results from a matched-pair analysis. Clinical Genitourinary Cancer. PMID: 36535810
  169. Sanapalli B, Yele V, Sigalapalli D, Gadewal N, Shaik A, Bhandare R, Annadurai S, Karri VVSR. (2022) Forging of nicotine for the effective management of diabetic wounds: A hybrid of scaffold hopping and molecular dynamics simulation approaches. Arabian Journal of Chemistry. 15(2): 103585.
  170. Sandbhor P, Goda JS, Mohanty B, Chaudhari P, Dutt S, Banerjee R (2022). Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy. Nanoscale. 14(35): 12773-12788. PMID: 36001382.
  171. Sawhney S, Thiagarajan S, Balaji A, Sathe P, Jain S, Rukmangathan TM, Kannan S, Shah S, Chaukar D.(2022) Results of sequential swallowing assessments in patients undergoing upfront surgery for oral tongue squamous cell carcinoma.Oral Oncology. 125:105684. PMID: 34963096
  172. Sen S, Khan PK, Wadasadawala T, Mohanty SK. Socio-economic and regional variation in breast and cervical cancer screening among Indian women of reproductive age: a study from National Family Health Survey, 2019-21. BMC Cancer. 22(1):1279. PMID: 36476339.
  173. Shah M, Noronha V, Ramaswamy A, Gattani S, Mokal S, Joshi A, Patil V, Menon S, Banavali S, Badwe R, Prabhash K (2022). G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer. Journal of Geriatric Oncology. 13(5):720-730PMID: 35283049
  174. Sharma A, Kumar A, Rashid M, Amnekar RV, Gupta S, Kaur J. (2022) A Phagosomally Expressed Gene, rv0428c, of Mycobacterium tuberculosis Demonstrates Acetyl Transferase Activity and Plays a Protective Role Under Stress Conditions. Protein Journal. 41(2):260-273. PMID: 35175508
  175. Sharma KS, Raju M S, Phapale S, Valvi SK, Dubey AK, Goswami D, Ray D, De A, Phadnis PP, Aswal VK, Vatsa R, Sarma HD (2022). Multimodal applications of zinc gallate-based persistent luminescent nanoparticles in cancer treatment: Tumor margining, diagnosis, and boron neutron capture therapy. ACS Applied Bio Materials. 5(7):3134-3145. PMID: 35758411.
  176. Shenoy P, Chakraborty S, Gaikwad S, Sakpal A, Ray P (2022). Developing clinically relevant acquired chemoresistance models in epithelial ovarian cancer cell lines. Bio-protocol. 12(3): e4310.
  177. Shetty A, Chatterjee G, Rajpal S, Srivastava T, Gardi N, Mirgh S, Gokarn A, Punatar S, Shetty N, Joshi A, Nair S, Murthy V, Khattry N, Tembhare P, Dikshit R, Chaturvedi P, More A, Kamtalwar S, Chavan P, Bhat V, Patil A, Dhumal S, Bhat P, Subramanian P, Gujral S, Badwe R, Patkar N, Gupta S.(2022) "Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai". International Journal of Clinical Practice. 2022: 24490682.PMID: 35685574
  178. Shetty D, Talker E, Dhamne C, Mohanty P, Chaubal K, Tembhare P, Patkar N, Subramanian PG, Moulik NR, Narula G, Banavali S (2022). Copy number gain of JAK2 on marker chromosome in a case of relapsed pediatric B-ALL. Pediatric Blood and Cancer. 69(10):e29658. PMID: 35373889.
  179. Shetty D, Talker E, Jain H, Talker J, Patkar N, Subramanian P, Jain H, Bonda A, Punatar S, Gokarn A, Bagal B, Sengar M, Khattry N (2022 ). Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation. Asia Pacific Journal of Clinical Oncology. 18(1):99-108 PMID: 33629824
  180. Shetty K, Yasaswi S, Dutt S, Yadav K (2022). Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy. 3Biotech. 12(11):301. PMID: 36276454
  181. Shriyan B, Mehta P, Patil A, Jadhav S, Kumar S, Puri AS, Govalkar R, Krishnamurthy MN, Punatar S, Gokarn A, Khattry N, Gota V (2022). Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia. European Journal of Clinical Pharmacology. 78(8):1321-1330. PMID: 35652931.
  182. Shukla P, Dange P, Mohanty BS, Gadewal N, Chaudhari P, Sarin R (2022). ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications. Cancer Gene Therapy. 29(12):1908-1917. PMID: PMID: 35869277
  183. Singh AG, Sathe P, Roy S, Thiagrajan S, Chaukar D, Chaturvedi P (2022).Incidence and impact of skip metastasis in the neck in early oral cancer: Reality or a myth? Oral Oncology. 135: 106201.PMID: 36242909
  184. Singh B, Roy Chowdhury S, Mansuri MS, Pillai SJ, Mehrotra S (2022). The BRCA2 and CDKN1A-interacting protein (BCCIP) stabilizes stalled replication forks and prevents degradation of nascent DNA. FEBS Letters. 596(16):2041-2055. PMID: 35592921
  185. Singh GP, Dholam KP, V Gurav S (2022). Revisiting Stage II MRONJ. Proposal for modification of AAOMS staging system: An institutional experience. Oral Diseases. 28(4):1289-1291. PMID: 34228868
  186. Singh P, Ambulkar R, Gupta A, Maji M (2022). Timely diagnosis and intervention in a case of portal vein thrombosis, Journal of Anaesthesiology Clinical Pharmacology.
  187. Sitani K, Parghane R, Talole S, Basu S (2022). The efficacy, toxicity and survival of salvage retreatment PRRT with 177Lu-DOTATATE in patients with progressive NET following initial course of PRRT. British Journal of Radiology. 95(1137): 20210896. PMID: 35816545.
  188. Soh KT, Came N, Otteson GE, Jevremovic D, Shi M, Olteanu H, Natoni A, Lagoo A, Theakston E, Óskarsson JÞ, Gorniak M, Grigoriadis G, Arroz M, Fletcher M, Lin P, Ludwig P, Tembhare P, Matuzeviciene R, Radzevicius M, Kay S, Chen W, Cabrita C, Wallace PK. (2022) Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis. Cytometry Part B: Clinical Cytometry. 102(2):88-106. PMID: 35005838
  189. Spampinato AS Jensen N, Pötter R, Fokdal L, Chargari C, Lindegaard J, Schmid M, Sturdza A, Ina M. Schulz J, Mahantshetty U, Hoskin P, Segedin B, Rai B, Bruheim K, Wiebe E, Steen-Banasik E, Cooper R, Limbergen E, Sundset M, Pieters B, Lutgens L, Tan L, Villafranca E, Smet S, Jastaniyah N, Nout R, Kirisits C, Chopra S, Kirchheiner K, Tanderup K (2022). EMBRACE Collaborative Group. Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future. International Journal of Radiation Oncology Biology Physics. 112(3):681-693.PMID: 34678431
  190. Spohn S, Draulans C, Kishan A, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra A, Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer L, Kirste S, Tselis N, Tran P, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann N, Wiegel T, Zilli T, Tree A, Qiu X, Murthy V, Epstein J, Graztke C, Gao X, Grosu A, Kamran S, Zamboglou C (2022). Genomic classifiers in personalized prostate cancer radiotherapy approaches – A systematic review and future perspectives based on international consensus. International Journal of Radiation Oncology, Biology Physics. PMID: 36596346
  191. Sreevidya TS, Dalvi S, Venkatraman P, Vemparala S. (2022) Structural insights on the effects of mutation of a charged binding pocket residue on phosphopeptide binding to 14-3-3ζ protein. Proteins: Structure, Function, and Bioinformatics. 90(5): 1179-1189. PMID: 35006623.
  192. Srinivasan S, Dasgupta A, Chatterjee A, Baheti A, Engineer R, Gupta T, Murthy V (2022). The promise of magnetic resonance imaging in radiation oncology practice in the management of brain, prostate, and GI malignancies. JCO Global Oncology. 8:e2100366 PMID: 35609219
  193. Sriram H, Kunjachan F, Khanka T, Gawai S, Ghogale S, Deshpande N, Girase K, Patil J, Chatterjee G, Rajpal S, Patkar NV, Bagal B, Jain H, Sengar M, Hasan SK, Khattry N, Subramanian PG, Gujral S, Tembhare PR( 2022). Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent. Cytometry B Clinical Cytometry. 102(6):462-470. PMID: 36346307.
  194. Starr NE, Moore JN, Shreckengost CSH, Fernandez K, Ambulkar RP, Capo-Chichi N, Varallo JE, Ademuyiwa AO, Krouch S, Rana PS, Ingabire JA, Weiser TG, Mammo TN, Evans FM (2022). Perioperative provider safety in the pandemic: Development, implementation and evaluation of an adjunct COVID-19 Surgical Patient Checklist. Anaesthesia and Intensive Care. 50(6):457-467. PMID: 35765829.
  195. Sthanam L, Roy T, Patwardhan S, Shukla A, Sharma S, Shinde P, Kale H, Shekar P, Kondabagil K, Sen S. (2022).MMP modulated differentiation of mouse embryonic stem cells on engineered cell derived matrices. 280:121268 .Biomaterials.PMID: 34871878
  196. Sulkshane P, Teni T (2022). Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it. Exploration of Targeted Anti-tumor Therapy. 3: 278–96. Sulkshane P, Teni T (2022). Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it. Exploration of Targeted Anti-tumor Therapy. 3: 278–96. PMID: 36045907
  197. Sunkara RR, Koulgi S, Jani V, Gadewal N, Sonavane U, Joshi R, Waghmare SK (2022).Understanding the binding affinities between SFRP1CRD, SFRP1Netrin, Wnt5B and frizzled receptors 2, 3 and 7 using MD simulations. Journal of Biomolecular Structure and Dynamics. 40(15):6831-6844. PMID: 33666148
  198. Sunkara RR, Mehta D, Sarate RM, Waghmare SK (2022). BMP-AKT-GSK3β signalling restores hair follicle stem cells decrease associated with loss of Sfrp1. Stem Cells. 40(9):802-817. PMID: 35689817.
  199. Swain M, Kannan S, Srinivasan S, Agarwal JP, Gupta T (2022). Concurrent cetuximab-based bioradiotherapy versus cisplatin-based chemoradiotherapy in the definitive management of favourable biology human papillomavirus-associated oropharyngeal squamous cell carcinoma: systematic review and meta-analysis. Clinical Oncology (R Coll Radiol) 34:786-795.
  200. Swamidas J, Jain J, Nesvacil N, Tanderup K, Kirisits C, Schmid M, Agarwal P, Joshi K, Naga P, Ranjan Khadanga C, Gudi S, Gurram L, Chopra S, Mahantshetty U. Dosimetric impact of target definition in brachytherapy for cervical cancer - Computed tomography and trans rectal ultrasound versus magnetic resonance imaging. Physics and Imaging in Radiation Oncology. 21:126-133. PMID: 35257030
  201. Talukdar R, Epari S, Sahay A, Choudhari A, Dasgupta A, Chatterjee A, Gupta T (2022). Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature. European Archives of Oto-Rhino-Laryngology. 279(5):2591-2598.PMID: 34410472
  202. Tambe M, Pinto A, D'Silva SZ, Singh M (2022). Identification of the novel HLA allele, HLA-DRB1*14:50:02, in an individual from southern India. HLA. 100(4):392-393. PMID: 35672230.
  203. Tembhare PR, Sriram HN, Chatterjee G, Khanka T, Gokarn A, Mirgh S, Rajendra A, Chaturvedi A, Ghogale SG, Deshpande N, Girase K, Dalvi K, Rajpal S, Patkar N, Trivedi B, Joshi A, Murthy V, Shetty N, Nair S, More A, Kamtalwar S, Chavan P, Bhat V, Bhat P, Subramanian PG, Gupta S, Khattry N (2022). Comprehensive immune cell profiling depicts an early immune response associated with severe COVID-19 disease in cancer patients. Immunology and Cell Biology. 100(1):61-73. PMID: 34582592.
  204. Tibdewal A, Pathak R, Kumar A, Anand S, Ghosh Laskar S, Sarin R, Chopra S, Engineer R, Laskar S, Murthy V, Gupta T, Agarwal JP (2022). Impact of the first Wave of COVID-19 pandemic on radiotherapy practice at Tata Memorial Centre, Mumbai: A longitudinal cohort study. JCO Global Oncology. PMID: 35802835.
  205. Turco F, Armstrong A, Attard G... Murthy V. et al. (2022). What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology. 82(1):6-11. PMID: 35393158
  206. Uthale A, Anatram A, Sulkshane P, Degani M, Teni T (2022). Identification of bicyclic compounds that act as dual inhibitors of Bcl-2 and Mcl-1. Molecular Diversity. PMID: 35909144
  207. Vahabi M, Lofters AK, Mishra G, Pimple S, Wong JP (2022). A family-centered sexual health intervention to promote cervical cancer screening uptake among low-income rural women in India: Protocol for a community-based mixed methods pilot study. JMIR Research Protocols. 11(9):e35093. PMID: 36074549
  208. Verghote F, Sargos P, Christodouleas JP, Murthy V, Baumann B, Dirix P, Berghen C, Paelinck L, Vercauteren T, Fonteyne V (2022). International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy: Update from an IBIS workgroup. Practical Radiation Oncology. 12(6):524-532. PMID: 35691550
  209. Vishwakarma GK, Kumari P, Bhattacharjee A.(2022) Thresholding of prominent biomarkers of breast cancer on overall survival using classification and regression tree. Cancer Biomarkers. 34(2):319-328. PMID: 35001879.
  210. Vu MT, Shalkow J, Naik- Mathuria B, Qureshi S, Ozgediz D, Lakhoo K, Abdelhafeez H, On behalf of the Pan African Paediatric Surgery Association (PAPSA) and Global Initiative for Children’s Surgery (GICS) initiative. Wilms’ tumor in low- and middle-income countries: survey of current practices, challenges, and priorities Annals of Pediatric Surgery (2022). 18:28.
  211. Waghmare M, Qureshi T, CM Krishna, Pansare K, Gadewal N, Hole A, Dongre P (2022). β-Lactoglobulin-gold nanoparticles interface and its interaction with some anticancer drugs – an approach for targeted drug delivery. Journal of Biomolecular and Structural Dynamics. 40(13):6193-6210. PMID: 33509048
  212. Yadav N, Sunder R, Desai S, Dharavath B, Chandrani P, Godbole M, Dutt A (2022). Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer. Breast Cancer Research. 24(1):97. PMID: 36578092.
Category
International
Select Year
2022
order
6
Back to Top